Kenvue

KVUE Consumer Staples Market cap $34.4B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Mar 30 – Jun 28, 2026 reported Aug 6, 2026

Revenue$3.96B +3% year over year

Gross profit$2.30B 58% margin

Operating profit$0.70B 18% margin

Net profit$0.46B 12% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 28, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.96	100%	+3%
Self care	1.70	43%	+9%
Essential health	1.15	29%	−6%
Skin health & beauty	1.06	27%	+0%
Other	0.05	1%
Cost of revenue	−1.65	42%
Gross profit	2.30	58% margin	−1pp
R&D	−0.09	3%	+0pp
SG&A	−1.51	38%	+0pp
Operating profit	0.70	18% margin	+0pp
Interest & other costs	−0.10
Tax	−0.14
Net profit	0.46	12% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 29, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.91	100%	+4%
Self care	1.70	44%	+2%
Essential health	1.15	29%	+5%
Skin health & beauty	1.06	27%	+8%
Cost of revenue	−1.61	41%
Gross profit	2.30	59% margin	+1pp
R&D	−0.08	2%	+0pp
SG&A	−1.45	37%	−4pp
Operating profit	0.77	20% margin	+5pp
Interest & other costs	−0.10
Tax	−0.20
Net profit	0.47	12% margin	+4pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.78	100%	+3%
Self care	1.59	42%	+1%
Essential health	1.15	30%	+6%
Skin health & beauty	1.04	28%	+3%
Cost of revenue	−1.64	43%
Gross profit	2.14	57% margin	+0pp
R&D	−0.10	2%	+0pp
SG&A	−1.50	40%	−1pp
Operating profit	0.54	14% margin	+1pp
Interest & other costs	−0.11
Tax	−0.10
Net profit	0.33	9% margin	+1pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 28, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.76	100%	−3%
Self care	1.56	41%	−4%
Essential health	1.16	31%	−3%
Skin health & beauty	1.04	28%	−3%
Cost of revenue	−1.54	41%
Gross profit	2.23	59% margin	+1pp
R&D	−0.09	2%	+0pp
SG&A	−1.50	40%	−1pp
Operating profit	0.63	17% margin	+0pp
Interest & other costs	−0.10
Tax	−0.13
Net profit	0.40	11% margin	+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 29, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.84	100%	−4%
Self care	1.56	40%	−5%
Essential health	1.23	32%	−3%
Skin health & beauty	1.06	28%	−4%
Cost of revenue	−1.58	41%
Gross profit	2.26	59% margin	+0pp
R&D	−0.09	2%	+0pp
SG&A	−1.48	39%	−2pp
Operating profit	0.69	18% margin	+14pp
Interest & other costs	−0.10
Tax	−0.17
Net profit	0.42	11% margin	+9pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Mar 30 – Jun 28, 2026 reported Aug 6, 2026 Operating margin 18% Net profit $0.46B	Mar 30 – Jun 28, 2026	Aug 6, 2026	$3.96B	+3%	18%	$0.46B	12%
Q1 FY26 Dec 29, 2025 – Mar 29, 2026 reported May 7, 2026 Operating margin 20% Net profit $0.47B	Dec 29, 2025 – Mar 29, 2026	May 7, 2026	$3.91B	+4%	20%	$0.47B	12%
Q4 FY25 Sep 29 – Dec 28, 2025 reported Feb 20, 2026 Operating margin 14% Net profit $0.33B	Sep 29 – Dec 28, 2025	Feb 20, 2026	$3.78B	+3%	14%	$0.33B	9%
Q3 FY25 Jun 30 – Sep 28, 2025 reported Nov 3, 2025 Operating margin 17% Net profit $0.40B	Jun 30 – Sep 28, 2025	Nov 3, 2025	$3.76B	−3%	17%	$0.40B	11%
Q2 FY25 Mar 31 – Jun 29, 2025 reported Aug 7, 2025 Operating margin 18% Net profit $0.42B	Mar 31 – Jun 29, 2025	Aug 7, 2025	$3.84B	−4%	18%	$0.42B	11%